Ru-Hong Tu

17PUBLICATIONS
35CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 22, 2026
Disrupting SRSF10-dependent BCAT2 exon skipping reprograms tumor-associated macrophages and enhances anti-PD-1 efficacy in gastric cancer.

|Apr 16, 2025
Targeting LHPP in neoadjuvant chemotherapy resistance of gastric cancer: insights from single-cell and multi-omics data on tumor immune microenvironment and stemness characteristics.

You-Xin Gao, Xiao-Jing Guo, Bin Lin

|Mar 07, 2025
Combining Apatinib and Oxaliplatin Remodels the Immunosuppressive Tumor Microenvironment and Sensitizes Desert-Type Gastric Cancer to Immunotherapy.

Guang-Tan Lin, Cheng Yan, Lu-Jie Li

|Jul 12, 2024
Increased ONECUT2 induced by Helicobacter pylori promotes gastric cancer cell stemness via an AKT-related pathway.

Mi Lin, Ru-Hong Tu, Sheng-Ze Wu

|May 31, 2024
Robotic versus laparoscopic distal gastrectomy for resectable gastric cancer: a randomized phase 2 trial.

Jun Lu, Bin-Bin Xu, Hua-Long Zheng

|Jan 03, 2024
Neoadjuvant camrelizumab and apatinib combined with chemotherapy versus chemotherapy alone for locally advanced gastric cancer: a multicenter randomized phase 2 trial.

Jian-Xian Lin, Yi-Hui Tang, Hua-Long Zheng

Pageof 3

Frequent Collaborators

11 joint publications

Chang-Ming Huang

7 joint publications

Chao-Hui Zheng

4 joint publications

Long-Long Cao

3 joint publications

Jian-Wei Xie